FCDGC
@FrontierCDG
Followers
457
Following
553
Media
65
Statuses
397
#NIH consortium fostering collaborative research among researchers, patients and clinicians, for congenital disorders of glycosylation (#CDG). RT/Like≠endorse
Joined April 2020
Late breaking update on current state of the #FCDGC Natural History study and its 280 participants with confirmed CDG, funded by RDRCN @ncats_nih_gov @NIH_NINDS and @NICHD_NIH Read more here: https://t.co/vfjWDRs9Mu
0
3
10
New research from @FrontierCDG: ✅ Evaluating the Use of #RNASequencing to Clarify Variants of Uncertain Significance in a Clinical Setting Listen and read more: https://t.co/dFs4bbT3OU
0
2
2
Evaluating the Use of #RNASequencing to Clarify Variants of Uncertain Significance in a Clinical Setting New in @GIMJournal from @FrontierCDG:
gimopen.org
Sequencing-based genetic testing often identifies variants of uncertain significance (VUS) or fails to detect pathogenic variants altogether. We evaluated the utility of RNA sequencing (RNA-seq) to...
0
5
10
New research from @FrontierCDG: ✅ Exploring the #NaturalHistory of #CongenitalDisordersOfGlycosylation Listen and subscribe: https://t.co/L76AdlNkLR
0
2
2
Exploring the Natural History of #CongenitalDisordersOfGlycosylation New in @ELS_Genetics from @FrontierCDG:
0
1
4
🚨 New podcast Friday 🚨 🎙 Heterozygous DHDDS Variants with Irena Muffels and Eva Morava. Listen on Apple 👉 https://t.co/iMXZrkPICV Spotify: https://t.co/wGK6sLWVsk Soundcloud: https://t.co/bt2TUOmTC6
@PerlaraPBC @CureDhdds @FrontierCDG @worldCDG
2
7
12
We urge the clinicians to regularly check coagulation parameters in individuals with PGM1-CDG and to prepare an emergency plan in case of vascular events. Thanks once again to all the co-authors and especially my summer student Sofie Bleukx for her efforts!
1
1
4
Nice news before the weekend! Our article is out in MGM! We show many coagulation parameters are abnormal in PGM1-CDG and that several patients reported major vascular events. Moreover AT could be used as a clinical endpoint for future trials https://t.co/WQ7ujWRcSx
@FrontierCDG
2
2
8
New paper drawing on data from @FrontierCDG Assessing age of onset and clinical symptoms over time in patients with heterozygous pathogenic DHDDS variants I. J. J. Muffels, et al https://t.co/y2i9wu0CRe
#cdg #dhdds #visualabstract
1
4
7
🎙 New podcast episode! ➡️ Investigating the Effects of #Glycan Extension Deficiency in #ALG3CDG Listen and subscribe: https://t.co/QsShuGB0HF
@FrontierCDG
0
1
7
New research from @FrontierCDG: ✅ Investigating the Effects of #Glycan Extension Deficiency in #ALG3CDG Listen and read more: https://t.co/qHpp0o3nXe
0
1
3
And what a better way to highlight the CDG than to share the latest research published in the special CDG issue of molecular genetics and metabolism! https://t.co/g0Br7g6U9s
#cdgawarnessday
2
3
7
Though there is still a long road ahead of us, it is clear that a tremendous progress has been made in the last years in the CDG field with the joint effort of patient organizations, patients, clinicians, scientists and caretakers. Go CDG! #cdgawarenessday @FrontierCDG
0
1
3
@FrontierCDG @budhraja_rohit @GlycomineBio Good news for FCKS deficiency patients? Starosta et al show clinical and biochemical improvement in a FCKS-CDG patient treated by oral mannose supplementation!
0
1
3
Another guidelines are out also for ALG13-CDG! Led by recently graduated Dr. Shah! https://t.co/nfhBexq2A1
@FrontierCDG
1
1
3
@FrontierCDG Out also this month, @budhraja_rohit et al in collaboration with @GlycomineBio show liposome encapsulated man-1-p is able to improve glycosylation in several CDG! https://t.co/mqhPGEyeX9
@FrontierCDG
2
1
5
Happy world CDG awareness day! here is to all the patient and their families! You motivate us to do better for CDG patients every day! @worldCDG @FrontierCDG @CDGCAREorg
0
2
5
New research from @FrontierCDG: ✅ Exploring #Proteomics and N-#Glycoproteomics in ALG1-#CongenitalDisorderOfGlycosylation (CDG) ✅ Exploring the #Neurological Characteristics of PMM2-CDG Using Human In Vitro Neural Models Listen and read more: https://t.co/0IXdSNj5qf
0
2
5
Investigating the Effects of Glycan Extension Deficiency in ALG3-CDG New research from @FrontierCDG:
onlinelibrary.wiley.com
ALG3-CDG is a rare congenital disorder of glycosylation (CDG) with a clinical phenotype that includes neurological manifestations, transaminitis, and frequent infections. The ALG3 enzyme catalyzes...
0
2
9
Delighted to announce our recent publication in Proteomics @WileyGlobal on an autosomal recessive disorder, ALG1-Congenital Disorder Glycosylation, led by Rohit Budhraja from our team @budhraja_rohit #glycotime #teammassspec @FrontierCDG
2
3
14